Evaluation of clinical efficacy, adverse reactions, and safety of PD-1 inhibitors combined with chemotherapy when treating advanced gastric cancer

OBJECTIVE: This paper aimed to assess the clinical efficacy, adverse reactions, and safety of employing PD-1 inhibitors in conjunction with chemotherapy as a treatment strategy for advanced gastric cancer (GC). METHODS: Ninety patients with advanced GC from January 2020 to December 2021 were divided...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Xue, He, Du, Lai, Lin, Chen, Jun, Zhang, Yukun, Mao, Huilin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619224/
https://www.ncbi.nlm.nih.gov/pubmed/37915064
http://dx.doi.org/10.1186/s12876-023-03011-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619224/
https://www.ncbi.nlm.nih.gov/pubmed/37915064
http://dx.doi.org/10.1186/s12876-023-03011-y

Ejemplares similares